Latest news
Loading news…
Juniper Biologics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Singapore, Central Region 11-50 employees For Profit
Juniper Biologics is developing novel therapies in oncology, rare/orphan diseases, and osteoarthritis health conditions.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
11
Patents
0
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 35
- Patents granted
- 0
- Trademarks
- 1
Company Info
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Sub-organizations
- 1
- News articles
- 6
- HQ
- Singapore, Central Region
- Region
- Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 2.6
- Trend (30d)
- 0
- Trend (90d)
- 1.3
Acquisitions by Juniper Biologics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Juniper Biologics
CEO
11
professional contacts at Juniper Biologics
Contact execs at Juniper Biologics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Juniper Biologics
Loading news…
FAQs about Juniper Biologics
People who checked this page also checked these
Sectors Juniper Biologics invests & acquires in
Browse the full Acquirezy directory.